drugset / Trial / NCT00258622
NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain
RandomizedCrossoverDouble-blindTreatment
Summary
Purpose: To evaluate the efficacy, tolerability and safety of NS1209 compared to lidocaine and placebo in patients with peripheral chronic neuropathic pain.
Timeline
- Start
- 2005-11
- Primary completion
- —
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | — | — |
| Subject | NS1209 | Unknown | — | — |
Indications
No indication recorded.